1 result(s) for Dabrafenib
| PI Name | Protocol # | Title |
|---|---|---|
| Matthew Taylor | IRB00008657 | A Phase III, randomised, open-label study comparing the combination of the BRAF inhibitor, dabrafenib and the MEK inhibitor, trametinib to the BRAF inhibitor vemurafenib in subjects with unresectable (stage IIIc) or metastatic (stage IV) BRAF V600E/K mutation positive cutaneous melanoma |
You may qualify for additional trials within our Phase 1 Program